Palatin Technologies Q2 Loss Narrower Than Estimate - Quick Facts

Biopharmaceutical company Palatin Technologies, Inc. (PTN) on Tuesday reported a net loss of $5.04 million or $0.02 per share for the second quarter, compared to net income of $3.03 million, or $0.01 per share in the prior-year quarter.

from RTT - Earnings http://bit.ly/2GG7MvV
via IFTTT